An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission
(2013)
Journal Article
Tarr, A. W., Lafaye, P., Meredith, L., Damier-Piolle, L., Urbanowicz, R. A., Meola, A., Jestin, J. L., Brown, R. J., Mckeating, J. A., Rey, F. A., Ball, J. K., & Krey, T. (2013). An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission. Hepatology, 58(3), 932-939. https://doi.org/10.1002/hep.26430
Severe liver disease caused by chronic hepatitis C virus is the major indication for liver transplantation. Despite recent advances in antiviral therapy, drug toxicity and unwanted side effects render effective treatment in liver-transplanted patient... Read More about An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission.